54 results
Page 3 of 3
8-K
EX-4
mwf97yy3pd
4 Jan 21
Agreement expands AzurRx’s pipeline of targeted, non-systemic GI therapies
7:32am
8-K
EX-4
hs0tdmefvg1 ow2qo
4 Jan 21
Agreement expands AzurRx’s pipeline of targeted, non-systemic GI therapies
7:32am
8-K
EX-4
oytn 4zt4apfqd
20 Jul 20
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
9:03am
8-K
EX-4.1
v62nynn s9k3lstnw6y
22 Jul 19
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
qps1 fy5kldve2mz
14 May 19
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.1
asgi6wnel35y
3 Apr 19
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-4.1
gbjqu rhtsjbzey2ko
4 May 18
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
12:00am
S-1/A
EX-4.3
apds0eelydf
29 Jul 16
IPO registration (amended)
12:00am
S-1/A
EX-4.1
hxfsjltjo
29 Jul 16
IPO registration (amended)
12:00am
S-1
EX-4.2
ffzkv9jcpw2r9ic
13 Jul 16
IPO registration
12:00am
DRS/A
EX-4.3
lps38
16 Oct 15
Draft registration statement (amended)
12:00am
DRS
EX-4.2
phmwi
8 Sep 15
Draft registration statement
12:00am